Skip to content

Gestalt vs Ibex Medical Analytics

Gestalt logo

Gestalt

Transforming Pathology Labs with AI-Powered Digital Pathology

31 employees · est. 2017 · Spokane, United States

VS
Ibex Medical Analytics logo

Ibex Medical Analytics

Pioneering AI-based cancer diagnostics in pathology

95 employees · est. 2016 · Brookline, United States

Ibex Medical Analytics is the older company (2017 vs 2016); Ibex Medical Analytics is the larger of the two.

Side-by-Side Comparison

Gestalt Ibex Medical Analytics
Founded
2017 2016 older
Headquarters
Spokane, United States Brookline, United States
Employees
31 95 larger
Industry
Biotechnology, Health Care AI, Analytics, Biotechnology
Funding Stage
Seed Series C
Total Funding
$4.58M $118.10M
Funding Rounds
2 7
Services
Not tracked yet AI-powered diagnostic solutions, Cancer detection in multiple tissue types, Biopharma clinical trials support, Translational research in drug development, Enhancing diagnostic workflows
Target Customers
Not tracked yet Pathologists, Healthcare systems, Diagnostic solution providers, Biopharma companies, Physicians
Taxonomy
Digital PathologyAI-poweredCloud-basedAnatomic PathologyInteroperabilityArtificial Intelligence Algorithms +8 AI-based Cancer DiagnosticsPathologyClinical-grade AlgorithmsDigital WorkflowsDiagnostic AccuracyComputer Vision +7
Website
gestaltdiagnostics.com ibex-ai.com
Gestalt logo

About Gestalt

Gestalt is a biotechnology and health care startup, founded in 2015, based in the United States. The company's slogan, "Transforming Pathology Labs with AI-Powered Digital Pathology," encapsulates its core mission. Gestalt offers PathFlow®, an AI-driven digital workflow solution for pathology labs,...

Ibex Medical Analytics logo

About Ibex Medical Analytics

Ibex Medical Analytics is at the forefront of revolutionizing the field of pathology through its pioneering AI-based cancer diagnostics. Founded in 2016, the company addresses the increasing challenges faced by pathologists, who struggle with overwhelming workloads, higher cancer prevalence, and the...

Also comparing in this category

Comparing more than these two?

Get Gestalt, Ibex Medical Analytics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Gestalt compare?

A PDF of Gestalt and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Gestalt was founded in 2017, based in Spokane, United States, with 31 employees. Gestalt is a biotechnology and health care startup, founded in 2015, based in the United States. The company's slogan, "Transforming Pathology Labs with AI-Powered Digital Pathology," encapsulates its. Ibex Medical Analytics was founded in 2016, based in Brookline, United States, with 95 employees. Ibex Medical Analytics is at the forefront of revolutionizing the field of pathology through its pioneering AI-based cancer diagnostics. Founded in 2016, the company addresses the increasing challenge.
Gestalt has raised $4.58M and Ibex Medical Analytics $118.10M. Latest stage: Gestalt Seed, Ibex Medical Analytics Series C.
Both work in Biotechnology and Health Care and list digital pathology and oncology among their focus areas.

Compare Gestalt with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Gestalt on 11 Sep 2024, and Ibex Medical Analytics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout